Overview

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Status:
Completed
Trial end date:
2008-01-07
Target enrollment:
Participant gender:
Summary
A Phase II trial to demonstrate the safety and efficacy of PTK 0796 in the treatment of complicated skin and skin structure infections (cSSSI).
Phase:
Phase 2
Details
Lead Sponsor:
Paratek Pharmaceuticals Inc
Treatments:
Linezolid